Full Product Details
Author: A. George Awad ,
Lakshmi N.P. Voruganti
Publisher: Springer International Publishing AG
Imprint: Adis
Edition: Softcover reprint of the original 1st ed. 2016
Weight: 0.503kg
ISBN: 9783319807157
ISBN 10: 3319807153
Pages: 224
Publication Date: 31 May 2018
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
The purpose is to advocate for refining conceptually the idea of quality of life in schizophrenia, bridging the present gaps and going beyond measurements to its significant applications in impacting clinical care and health economics. ... It is relevant for researchers evaluating treatment efficacy in terms of quality of life changes and clinicians who need to look beyond symptom reduction and how treatment affects the life of these individuals. (Michael Easton, Doody's Book Reviews, November, 2016)
“The purpose is to advocate for refining conceptually the idea of quality of life in schizophrenia, bridging the present gaps and going beyond measurements to its significant applications in impacting clinical care and health economics. … It is relevant for researchers evaluating treatment efficacy in terms of quality of life changes and clinicians who need to look beyond symptom reduction and how treatment affects the life of these individuals.” (Michael Easton, Doody's Book Reviews, November, 2016)
Author Information
Dr. A. George Awad is a professor emeritus in the Department of Psychiatry and the Institute of Medical Science, University of Toronto, Canada. Until recently, Dr. Awad served as the Founding President of the International Society of CNS Clinical Trials Methodology, and also as the Psychiatrist-in-Chief of Humber River Hospital, in Toronto. He is the recipient of numerous awards, including the Canadian College of Neuropsychopharmacology Medal for meritorious contributions to neuropsychopharmacology, the Joey and Toby Tanenbaum Award for distinguished researcher in schizophrenia, and, recently, the Andrew C. Leon Distinguished Career Award in CNS clinical trial methodology and neurosciences. Over his forty-five years of academic and research contributions, Dr. Awad dedicated his research focus on the “person” behind the illness and the outcomes that matter most to the patient. Dr. Lakshmi N.P. Voruganti joined Dr. Awad as both a Master’s and PhD candidate, and made significant contributions exploring and extending Dr. Awad’s early research contributions, particularly in the area of neurobiology of subjective tolerability to antipsychotic medications. After gaining his PhD degree, he pursued an independent clinical research career as an associate professor at the University of Western Ontario, London, Ontario, Canada and, later, at McMaster’s University in Hamilton, Ontario. At present, he is a practicing psychiatrist at Oakville-Trafalgar Memorial Hospital in Oakville, Ontario, Canada.
